Cargando…
Comparison of the 2021 COVID-19 roadmap projections against public health data in England
Control and mitigation of the COVID-19 pandemic in England has relied on a combination of vaccination and non-pharmaceutical interventions (NPIs). Some of these NPIs are extremely costly (economically and socially), so it was important to relax these promptly without overwhelming already burdened he...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395530/ https://www.ncbi.nlm.nih.gov/pubmed/35995764 http://dx.doi.org/10.1038/s41467-022-31991-0 |
_version_ | 1784771715664969728 |
---|---|
author | Keeling, Matt J. Dyson, Louise Tildesley, Michael J. Hill, Edward M. Moore, Samuel |
author_facet | Keeling, Matt J. Dyson, Louise Tildesley, Michael J. Hill, Edward M. Moore, Samuel |
author_sort | Keeling, Matt J. |
collection | PubMed |
description | Control and mitigation of the COVID-19 pandemic in England has relied on a combination of vaccination and non-pharmaceutical interventions (NPIs). Some of these NPIs are extremely costly (economically and socially), so it was important to relax these promptly without overwhelming already burdened health services. The eventual policy was a Roadmap of four relaxation steps throughout 2021, taking England from lock-down to the cessation of all restrictions on social interaction. In a series of six Roadmap documents generated throughout 2021, models assessed the potential risk of each relaxation step. Here we show that the model projections generated a reliable estimation of medium-term hospital admission trends, with the data points up to September 2021 generally lying within our 95% prediction intervals. The greatest uncertainties in the modelled scenarios came from vaccine efficacy estimates against novel variants, and from assumptions about human behaviour in the face of changing restrictions and risk. |
format | Online Article Text |
id | pubmed-9395530 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-93955302022-08-23 Comparison of the 2021 COVID-19 roadmap projections against public health data in England Keeling, Matt J. Dyson, Louise Tildesley, Michael J. Hill, Edward M. Moore, Samuel Nat Commun Article Control and mitigation of the COVID-19 pandemic in England has relied on a combination of vaccination and non-pharmaceutical interventions (NPIs). Some of these NPIs are extremely costly (economically and socially), so it was important to relax these promptly without overwhelming already burdened health services. The eventual policy was a Roadmap of four relaxation steps throughout 2021, taking England from lock-down to the cessation of all restrictions on social interaction. In a series of six Roadmap documents generated throughout 2021, models assessed the potential risk of each relaxation step. Here we show that the model projections generated a reliable estimation of medium-term hospital admission trends, with the data points up to September 2021 generally lying within our 95% prediction intervals. The greatest uncertainties in the modelled scenarios came from vaccine efficacy estimates against novel variants, and from assumptions about human behaviour in the face of changing restrictions and risk. Nature Publishing Group UK 2022-08-22 /pmc/articles/PMC9395530/ /pubmed/35995764 http://dx.doi.org/10.1038/s41467-022-31991-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Keeling, Matt J. Dyson, Louise Tildesley, Michael J. Hill, Edward M. Moore, Samuel Comparison of the 2021 COVID-19 roadmap projections against public health data in England |
title | Comparison of the 2021 COVID-19 roadmap projections against public health data in England |
title_full | Comparison of the 2021 COVID-19 roadmap projections against public health data in England |
title_fullStr | Comparison of the 2021 COVID-19 roadmap projections against public health data in England |
title_full_unstemmed | Comparison of the 2021 COVID-19 roadmap projections against public health data in England |
title_short | Comparison of the 2021 COVID-19 roadmap projections against public health data in England |
title_sort | comparison of the 2021 covid-19 roadmap projections against public health data in england |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395530/ https://www.ncbi.nlm.nih.gov/pubmed/35995764 http://dx.doi.org/10.1038/s41467-022-31991-0 |
work_keys_str_mv | AT keelingmattj comparisonofthe2021covid19roadmapprojectionsagainstpublichealthdatainengland AT dysonlouise comparisonofthe2021covid19roadmapprojectionsagainstpublichealthdatainengland AT tildesleymichaelj comparisonofthe2021covid19roadmapprojectionsagainstpublichealthdatainengland AT hilledwardm comparisonofthe2021covid19roadmapprojectionsagainstpublichealthdatainengland AT mooresamuel comparisonofthe2021covid19roadmapprojectionsagainstpublichealthdatainengland |